Jabed Iqbal

3.6k total citations · 1 hit paper
69 papers, 2.2k citations indexed

About

Jabed Iqbal is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jabed Iqbal has authored 69 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 19 papers in Molecular Biology and 16 papers in Cancer Research. Recurrent topics in Jabed Iqbal's work include Cancer Immunotherapy and Biomarkers (18 papers), Cancer Cells and Metastasis (12 papers) and Breast Cancer Treatment Studies (10 papers). Jabed Iqbal is often cited by papers focused on Cancer Immunotherapy and Biomarkers (18 papers), Cancer Cells and Metastasis (12 papers) and Breast Cancer Treatment Studies (10 papers). Jabed Iqbal collaborates with scholars based in Singapore, United States and Hong Kong. Jabed Iqbal's co-authors include Aye Aye Thike, Joe Yeong, Puay Hoon Tan, Puay Hoon Tan, Jeffrey Chun Tatt Lim, Rebecca Dent, Dong‐An Wang, Wenzhen Zhu, Huihua Li and Poh Yian Cheok and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biomaterials.

In The Last Decade

Jabed Iqbal

67 papers receiving 2.2k citations

Hit Papers

PD1 blockade with pembrolizumab is highly effective in re... 2017 2026 2020 2023 2017 100 200 300

Peers

Jabed Iqbal
Julie M. Jorns United States
Sherine F. Elsawa United States
Philip Cohen United States
John C. Krauss United States
Dita Gratzinger United States
Wayne R. Godfrey United States
Julie M. Jorns United States
Jabed Iqbal
Citations per year, relative to Jabed Iqbal Jabed Iqbal (= 1×) peers Julie M. Jorns

Countries citing papers authored by Jabed Iqbal

Since Specialization
Citations

This map shows the geographic impact of Jabed Iqbal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jabed Iqbal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jabed Iqbal more than expected).

Fields of papers citing papers by Jabed Iqbal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jabed Iqbal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jabed Iqbal. The network helps show where Jabed Iqbal may publish in the future.

Co-authorship network of co-authors of Jabed Iqbal

This figure shows the co-authorship network connecting the top 25 collaborators of Jabed Iqbal. A scholar is included among the top collaborators of Jabed Iqbal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jabed Iqbal. Jabed Iqbal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Lu, Danping Wu, Yiwen Wang, et al.. (2025). Empowering hypoxia to convert cold tumors into hot tumors for breast cancer immunotherapy. Cell Death Discovery. 11(1). 381–381. 2 indexed citations
2.
Rahman, Arman, et al.. (2025). Digital pathology and AI: enhancing molecular diagnostics in low- and middle-income countries. Expert Review of Molecular Diagnostics. 25(12). 859–867.
3.
Yeong, Joe, Denise Goh, Tira J. Tan, et al.. (2023). Early Triple-Negative Breast Cancers in a Singapore Cohort Exhibit High PIK3CA Mutation Rates Associated With Low PD-L1 Expression. Modern Pathology. 36(4). 100056–100056. 3 indexed citations
4.
Ghoshdastider, Umesh, Neha Rohatgi, Marjan Mojtabavi Naeini, et al.. (2021). Pan-Cancer Analysis of Ligand–Receptor Cross-talk in the Tumor Microenvironment. Cancer Research. 81(7). 1802–1812. 48 indexed citations
5.
Chong, Pek Yoon, Jabed Iqbal, Joe Yeong, et al.. (2021). Immune Response in Myocardial Injury: In Situ Hybridization and Immunohistochemistry Techniques for SARS-CoV-2 Detection in COVID-19 Autopsies. Frontiers in Molecular Biosciences. 8. 658932–658932. 3 indexed citations
7.
Lee, Kian Leong, Shanshan Cheng, Jia Li, et al.. (2020). SRSF1 mediates cytokine-induced impaired imatinib sensitivity in chronic myeloid leukemia. Leukemia. 34(7). 1787–1798. 21 indexed citations
8.
Tao, Chao, et al.. (2020). Autologous cell membrane coatings on tissue engineering xenografts for suppression and alleviation of acute host immune responses. Biomaterials. 258. 120310–120310. 39 indexed citations
9.
Yeong, Joe, An S. Tan, Clara Chong Hui Ong, et al.. (2019). Evaluation of phospho-histone H3 in Asian triple-negative breast cancer using multiplex immunofluorescence. Breast Cancer Research and Treatment. 178(2). 295–305. 9 indexed citations
10.
Yeong, Joe, Jeffrey Chun Tatt Lim, Bernett Lee, et al.. (2018). High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer. Frontiers in Immunology. 9. 1209–1209. 100 indexed citations
11.
Liew, Oi Wah, Jabed Iqbal, Yuezhen Xue, et al.. (2018). Monoclonal Antibodies against Specific p53 Hotspot Mutants as Potential Tools for Precision Medicine. Cell Reports. 22(1). 299–312. 39 indexed citations
12.
Yeong, Joe, Aye Aye Thike, Jeffrey Chun Tatt Lim, et al.. (2017). Caveolin-1 expression as a prognostic marker in triple negative breast cancers of Asian women. Journal of Clinical Pathology. 71(2). 161–167. 22 indexed citations
13.
Zhu, Wenzhen, Jian Yang, Jabed Iqbal, et al.. (2017). A mussel-inspired double-crosslinked tissue adhesive on rat mastectomy model: seroma prevention and in vivo biocompatibility. Journal of Surgical Research. 215. 173–182. 20 indexed citations
14.
Salcido-Ochoa, Francisco, Susan Swee‐Shan Hue, Siyu Peng, et al.. (2017). Histopathological analysis of infiltrating T cell subsets in acute T cell-mediated rejection in the kidney transplant. World Journal of Transplantation. 7(4). 222–222. 9 indexed citations
15.
Matsumoto, Hirofumi, Aye Aye Thike, Huihua Li, et al.. (2016). Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer. Breast Cancer Research and Treatment. 156(2). 237–247. 121 indexed citations
16.
Thike, Aye Aye, Jabed Iqbal, Wei Sean Yong, et al.. (2013). Sentinel lymph nodes with isolated tumour cells and micrometastases in breast cancer: clinical relevance and prognostic significance. Journal of Clinical Pathology. 67(3). 243–250. 11 indexed citations
17.
Sim, Yirong, et al.. (2013). Primary melanoma of the esophagus, a diagnostic challenge. Asian Journal of Surgery. 38(4). 236–238. 4 indexed citations
18.
Iqbal, Jabed, Aye Aye Thike, Poh Yian Cheok, Gary M. Tse, & Puay Hoon Tan. (2012). Insulin growth factor receptor‐1 expression and loss of PTEN protein predict early recurrence in triple‐negative breast cancer. Histopathology. 61(4). 652–659. 35 indexed citations
19.
Ahmed, Shaheda, Jabed Iqbal, Aye Aye Thike, et al.. (2010). HER2/neu revisited: quality and interpretive issues. Journal of Clinical Pathology. 64(2). 120–124. 15 indexed citations
20.
Iqbal, Jabed, et al.. (1990). Blood chemistry of clinical metritis in Nili-Ravi buffaloes of two age-groups and at two stages of lactation.. Pakistan Veterinary Journal. 10(2). 55–59. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026